| Literature DB >> 35618184 |
Darren L Richardson1, Jason Tallis2, Michael J Duncan2, Neil D Clarke2, Tony D Myers3.
Abstract
Coronavirus (COVID-19) and its variants, continue to spread globally more than two years after the discovery of the wild-type virus in Wuhan, China. Following the onset of COVID-19, fluctuating restrictions have likely impacted the daily lives of older adults living in the United Kingdom (UK). Subsequently, the longer term effects of COVID-19 on physical activity levels, perceived physical function and mood of older adults are unclear. Therefore, the present study aimed to follow a group of older adult's living in the UK for one year, to monitor physical activity levels, perceived physical function and mood. A longitudinal, mixed-methods, observational study was conducted using self-administered, online surveys at 3-month intervals between March 2020 and June 2021. A total of 100 participants (46 males [age: 76 ± 5 years] and 54 females [age:74 ± 4 years]) completed all surveys. Bayesian analysis allowed calculation of direct probabilities whilst incorporating our prior knowledge. Throughout this period, older adults maintained or increased their pre-lockdown physical activity levels despite a decrease in intensity of effort of physical activity tasks, whilst sitting time increased at two of the follow-up time-points. Furthermore, perceived physical function decreased (ps = 91.78%;>1.21 AU) and mood undulated in a pattern that reflected the tightening and easing of restrictions. Despite total physical activity being maintained, perceived physical function decreased by a small but clinically meaningful margin.Entities:
Keywords: COVID-19; Older adults; Physical activity
Mesh:
Year: 2022 PMID: 35618184 PMCID: PMC9126621 DOI: 10.1016/j.exger.2022.111838
Source DB: PubMed Journal: Exp Gerontol ISSN: 0531-5565 Impact factor: 4.253
Fig. 1Cumulative cases and deaths data are derived from the closest update given by the WHO (WHO, 2020) to the last day in each month; Time line updates are provided by the Institute for government (Institute For Government, 2021); PHASE 1-5 updates from Sport England provide an overview of activity trajectories and permissions (Sport England, 2022); WHO = World Health Organisation; COVID-19 = Coronavirus.
Participant characteristics.
| Male | Female | Total | ||
|---|---|---|---|---|
| Sample Size ( | 46 | 54 | 100 | |
| Age (years) | 76 ± 5 (70–90) | 74 ± 4 (70–87) | 75 ± 4 | |
| Ethnicity ( | White British: 43 | White British: 47 | White British: 90 | |
| White Other: 3 | White Other: 7 | White Other: 10 | ||
| Education Qualification Level (0–8) | 5 ± 2 (0–8) | 5 ± 2 (0–8) | 5 ± 2 | |
| Living Situation ( | Partner/ Spouse | 34 | 35 | 69 |
| Alone | 9 | 17 | 26 | |
| Other Family member(s) | 3 | 1 | 4 | |
| A friend | 0 | 1 | 1 | |
| Residence type ( | House | 35 | 40 | 75 |
| Flat/Apartment | 4 | 7 | 11 | |
| Bungalow | 7 | 6 | 13 | |
| Mobile Home | 0 | 1 | 1 | |
| Have a medical condition that affects physical/ mental health ( | 15 | 12 | 27 | |
| Consider themselves limited in physical function ( | 6 | 6 | 12 | |
| Have a carer once or twice weekly ( | 2 | 2 | 4 | |
| Cigarette smokers ( | Current Smokers | 2 | 0 | 2 |
| Ex-smokers | 27 | 24 | 51 | |
| Never Smoked | 17 | 30 | 47 | |
| Self-reported meeting the current PA guidelines ( | All guidelines | 21 | 21 | 42 |
| Parts of guidelines | 24 | 32 | 56 | |
| No guidelines | 1 | 1 | 2 | |
| Parts of the guidelines being met ( | Active everyday | 24 | 32 | 56 |
| Strength/ balance at least 2 days per week | 14 | 20 | 34 | |
| 150 mins moderate (75 mins vigorous) PA | 12 | 14 | 26 | |
| PA levels at baseline (MET-min/ week) using IPAQ-E data median (interquartile range) | 2964 (4318) | 2670 (3348) | 2750 (3578) | |
Note: Values are presented as Mean ± SD and (Range) other values indicate how many participants (n =) fell into each category; MET-mins data is presented as median and (interquartile range); Qualification level is graded on the Regulated Qualifications Framework (RQF) for England and Northern Ireland; M = Male; F = Female; IPAQ-E = International Physical Activity Questionnaire- Elderly; PA = Physical Activity.
Estimated marginal means and 95% credible intervals of the best fitting models for each measure across the follow up period with interactions for sex.
| Time | IPAQ-E | IPAQ-E sitting | Tension | Depression | Anger | Vigour | Fatigue | Confusion | LLFDI limitation | LLFDI frequency | LLFDI function |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-COVID-19 | 4094 (3651: 4581) | 405 (382: 429) | 1.9 (1.47: 2.34) | 1.75 (1.25: 2.21) | 1.79 (1.43: 2.17) | 9.62 (8.92: 10.33) | 3.35 (2.83: 3.87) | 1.29 (0.92: 1.67) | 75.7 (72.7:78.8) | 55.2 (54.2: 56.4) | 70.4 (68.1: 72.7) |
| Follow-up 1 ( | 4261 (3784: 4762) | 420 (396: 445) | 1.84 (1.42: 2.29) | 1.76 (1.26: 2.24) | 1.53 (1.18: 1.86) | 8.96 (8.25: 9.66) | 2.8 (2.29: 3.32) | 1.28 (0.91: 1.65) | 55.9 (54.4: 57.5) | 44.2 (43.3: 45.2) | 70.2 (67.9: 72.5) |
| Follow up 2 | 4279 (3814: 4785) | 409 (384: 433) | 1.89 (1.46: 2.33) | 1.85 (1.36: 2.33) | 1.59 (1.26: 1.92) | 8.70 (8.02: 9.43) | 3.19 (2.68: 3.73) | 1.44 (1.05: 1.81) | 60.0 (58.4: 61.6) | 47.2(46.3: 48.2) | 69.5 (67.2: 71.7) |
| Follow-up 3 | 3921 (3449: 4414) | 410 (386: 435) | 1.91 (1.49: 2.35) | 2.05 (1.54: 2.53) | 1.69 (1.35: 2.04) | 8.48 (7.81: 9.18) | 2.83 (2.32: 3.33) | 1.38 (1.01: 1.76) | 56.3 (54.9: 57.9) | 45.3 (44.4: 46.3) | 69.2 (66.9:71.5) |
| Follow-up 4 | 4027 (3521: 4495) | 417 (391: 441) | 1.86 (1.43: 2.30) | 1.96 (1.46: 2.46) | 1.51 (1.18: 1.85) | 8.58 (7.89: 9.26) | 3.1 (2.59: 3.62) | 1.59 (1.22: 1.97) | 55.6 (54.1: 57.2) | 45.1 (44.1: 46.0) | 68.9 (66.6: 71.1) |
| Follow-up 5 | 4204 (3734: 4710) | 405 (380: 430) | 1.85 (1.41: 2.28) | 1.75 (1.23: 2.21) | 1.46 (1.13: 1.79) | 8.80 (8.11: 9.51) | 3.24 (2.72: 3.75) | 1.25 (0.88: 1.62) | 63.3 (61.6: 65.1) | 48.8 (47.8: 49.8) | 68.7 (66.4: 70.9) |
| Female | |||||||||||
| Pre-COVID-19 | 4087 (3620: 4563) | 407 (384: 432) | 2.25 (1.63: 2.83) | 2.05 (1.36: 2.75) | 1.71 (1.23: 2.20) | 10.01 (9.07: 10.94) | 2.98 (2.25: 3.67) | 1.10 (0.59: 1.61) | 74.5 (69.7: 79.5) | 56.8 (55.5: 58.2) | 68.9 (65.5: 72.0) |
| Follow-up 1 | 4220 (3752: 4740) | 421 (394: 446) | 2.09 (1.49: 2.68) | 2.13 (1.45: 2.85) | 1.45 (0.98: 1.91) | 9.40 (8.43: 10.34) | 2.26 (1.55: 3.01) | 1.46 (0.96: 1.97) | 54.5 (52.5: 56.5) | 45.4 (44.1: 46.7) | 69.2 (65.9: 72.5) |
| Follow up 2 | 4251 (3765: 4746) | 412 (387: 438) | 2.29 (1.67: 2.86) | 2.20 (1.53: 2.90) | 1.51 (1.05: 1.95) | 8.39 (7.45: 9.34) | 2.92 (2.21: 3.67) | 1.39 (0.89: 1.91) | 58.9 (56.8: 61.1) | 48.2 (46.9: 49.5) | 67.9 (64.6: 71.2) |
| Follow-up 3 | 3935 (3458: 4443) | 412 (386: 437) | 2.29 (1.70: 2.86) | 2.48 (1.81: 3.20) | 1.60 (1.14: 2.05) | 8.53 (7.58: 9.44) | 2.44 (1.76: 3.20) | 1.61 (1.10: 2.12) | 55.1 (53.0: 57.1) | 46.7 (45.4: 48.0) | 67.4 (64.0: 70.6) |
| Follow-up 4 | 4038 (3558: 4532) | 419 (394: 445) | 2.23 (1.65: 2.82) | 2.31 (1.64: 3.00) | 1.50 (1.03: 1.95) | 8.63 (7.69: 9.56) | 2.79 (2.10: 3.51) | 1.41 (0.91: 1.94) | 54.3 (52.3: 56.4) | 45.8 (44.5: 47.1) | 67.1 (63.7: 70.3) |
| Follow-up 5 | 4180 (3681: 4672) | 406 (379: 430) | 2.22 (1.64: 2.81) | 2.10 (1.39: 2.78) | 1.36 (0.92: 1.82) | 9.00 (8.03: 9.95) | 2.91 (2.19: 3.64) | 1.31 (0.80: 1.82) | 62.7 (60.3: 64.9) | 49.6 (48.3: 50.9) | 66.7 (63.5: 70.1) |
| Male | |||||||||||
| Pre-COVID-19 | 4102 (3624: 4572) | 406 (381: 430) | 1.53 (0.89: 2.23) | 1.39 (0.62: 2.09) | 1.93 (1.38: 2.47) | 9.21 (8.17: 10.22) | 3.4 (2.65: 4.17) | 1.51 (0.97: 2.06) | 77.2 (73.7: 80.8) | 54.3 (52.8: 55.6) | 73.3 (69.8: 76.8) |
| Follow-up 1 | 4309 (3788: 4822) | 423 (396: 451) | 1.5 (0.86: 2.19) | 1.36 (0.6: 2.08) | 1.62 (1.14: 2.13) | 8.53 (7.52: 9.56) | 3.55 (2.8: 4.33) | 1.41 (0.85: 1.95) | 57.8 (55.3: 60.0) | 44.8 (43.4: 46.3) | 71.8 (68.4: 75.4) |
| Follow up 2 | 4310 (3816: 4840) | 406 (378: 433) | 1.48 (0.84: 2.15) | 1.47 (0.71: 2.2) | 1.69 (1.21: 2.19) | 9.02 (8.00: 10.07) | 3.31 (2.56: 4.06) | 1.38 (0.85: 1.96) | 61.4 (59.2: 63.7) | 48.4 (47.0: 49.8) | 70.3 (67.0: 73.9) |
| Follow-up 3 | 3910 (3394: 4421) | 410 (382: 438) | 1.51 (0.85: 2.18) | 1.62 (0.86: 2.36) | 1.83 (1.33: 2.33) | 8.45 (7.44: 9.46) | 3.51 (2.71: 4.27) | 1.58 (1.04: 2.14) | 57.8 (55.6: 59.9) | 45.6 (44.2: 47.1) | 70.2(66.8: 73.8) |
| Follow-up 4 | 4021 (3488: 4524) | 419 (389: 445) | 1.42 (0.79: 2.10) | 1.63 (0.87: 2.39) | 1.54 (1.04: 2.04) | 8.56 (7.58: 9.58) | 3.66 (2.91: 4.44) | 1.08 (0.53: 1.62) | 57.2 (55.1: 59.5) | 45.6 (44.2: 47.1) | 70.2 (66.6: 73.6) |
| Follow-up 5 | 4225 (3717: 4761) | 407 (380: 436) | 1.41 (0.76: 2.06) | 1.34 (0.58: 2.05) | 1.59 (1.10: 2.08) | 8.59 (7.54: 9.61) | 3.40 (2.65: 4.17) | 1.26 (0.71: 1.82) | 64.1 (61.6: 66.4) | 48.6 (47.1: 50.0) | 69.9(66.4: 73.4) |
Note: IPAQ-E = International Physical Activity Questionnaire –Elderly; LLFDI = Late-Life Function and Disability Instrument; Dates = Follow-up 1 (13/6/2020), Follow-up 2 (5/9/2020) Follow-up 3 (12/12/2020), Follow-up 4 (6/3/2021), Follow-up 5 (5/6/2021).
Key differences for each measure across the follow up period and associated probability of direction as a percentage.
| IPAQ_E | IPAQ-sitting | Tension | Depression | Anger | Vigour | Fatigue | Confusion | LLFDI frequency | LLFDI limitation | LLFDI function | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contrasts | Diff | pd | Diff | pd | Diff | pd | Diff | pd | Diff | Pd | Diff | pd | Diff | pd | Diff | pd | Diff | pd | Diff | pd | Diff | pd |
| Pre COVID-19 - Follow-up 1 | −135.2 | 93.19% | −14.83 | 0.05 | 77.99% | −0.02 | 77.99% | 0.26 | 93.92% | 0.65 | 0.56 | 0.00 | 50.23% | 11.02 | 19.75 | 0.25 | 73.95% | |||||
| Pre COVID-19 - Follow-up 2 | −164.7 | −3.13 | 68.80% | 0.01 | 56.09% | −0.10 | 56.09% | 0.20 | 76.45% | 0.92 | 0.16 | 79.50% | −0.15 | 79.58% | 8.04 | 15.64 | 0.94 | |||||
| Pre COVID-19 - Follow-up 3 | 162.4 | −4.66 | 75.86% | −0.01 | 54.77% | −0.30 | 54.77% | 0.10 | 1.14 | 0.52 | −0.10 | 70.79% | 9.93 | 19.35 | 1.21 | |||||||
| Pre COVID-19 - Follow-up 4 | 58.0 | 73.99% | −11.93 | 0.04 | 73.17% | −0.21 | 73.17% | 0.28 | 1.04 | 0.25 | 90.54% | −0.31 | 10.17 | 20.06 | 1.51 | |||||||
| Pre COVID-19 - Follow-up 5 | −93.3 | 84.71% | 0.59 | 53.63% | 0.05 | 77.33% | 0.00 | 77.33% | 0.33 | 0.82 | 0.12 | 72.78% | 0.03 | 56.75% | 6.49 | 12.35 | 1.74 | |||||
| Follow-up 1 - Follow-up 2 | −31.5 | 59.48% | 11.67 | 92.87% | −0.04 | 74.90% | −0.08 | 74.90% | −0.06 | 82.23% | 0.26 | 84.17% | −0.40 | −0.15 | 80.19% | −2.97 | −4.11 | 0.69 | ||||
| Follow-up 1 - Follow-up 3 | 296.9 | 10.24 | 89.92% | −0.06 | 83.34% | −0.28 | 83.34% | −0.17 | 75.03% | 0.48 | −0.04 | 57.79% | −0.10 | 71.69% | −1.09 | −0.39 | 73.58% | 0.96 | ||||
| Follow-up 1 - Follow-up 4 | 191.9 | 2.97 | 63.63% | −0.01 | 56.93% | −0.19 | 56.93% | 0.02 | 86.84% | 0.38 | 93.15% | −0.31 | −0.31 | −0.84 | 0.33 | 69.44% | 1.26 | |||||
| Follow-up 1 - Follow-up 5 | 41.3 | 63.00% | 15.51 | 0.00 | 52.36% | 0.01 | 52.36% | 0.06 | 69.59% | 0.17 | 73.13% | −0.44 | 0.03 | 56.40% | −4.52 | −7.39 | 1.49 | |||||
| Follow-up 2 - Follow-up 3 | 327.4 | −1.52 | 58.04% | −0.02 | 61.62% | −0.20 | 61.62% | −0.11 | 94.03% | 0.22 | 79.97% | 0.36 | 0.05 | 60.97% | 1.89 | 3.72 | 0.27 | 80.30% | ||||
| Follow-up 2 - Follow-up 4 | 220.7 | −8.78 | 86.00% | 0.03 | 69.69% | −0.11 | 69.69% | 0.08 | 0.12 | 67.72% | 0.09 | 68.44% | −0.16 | 81.21% | 2.14 | 4.44 | 0.56 | |||||
| Follow-up 2 - Follow-up 5 | 71.6 | 71.99% | 3.65 | 68.14% | 0.04 | 73.80% | 0.10 | 73.80% | 0.12 | 92.22% | −0.10 | 64.65% | −0.05 | 59.39% | 0.18 | 84.00% | −1.55 | −3.28 | 0.80 | |||
| Follow-up 3 - Follow-up 4 | −104.9 | 80.76% | −7.32 | 81.25% | 0.05 | 78.69% | 0.08 | 78.69% | 0.19 | 65.37% | −0.10 | 65.22% | −0.27 | 93.33% | −0.21 | 87.93% | 0.25 | 72.45% | 0.71 | 87.54% | 0.29 | 82.56% |
| Follow-up 3 - Follow-up 5 | −255.9 | 5.24 | 74.21% | 0.05 | 82.03% | 0.29 | 82.03% | 0.23 | 55.97% | −0.31 | 89.27% | −0.40 | 0.13 | 76.41% | −3.44 | −7.00 | 0.53 | |||||
| Follow-up 4 - Follow-up 5 | −149.9 | 89.01% | 12.43 | 93.58% | 0.01 | 54.81% | 0.21 | 54.81% | 0.04 | 71.14% | −0.22 | 80.27% | −0.13 | 76.84% | 0.34 | −3.68 | −7.71 | 0.24 | 76.62% | |||
| Female Pre COVID - Follow-up 5 | −92.18 | 84.30% | 1.59 | 59.52% | 0.03 | 58.97% | −0.05 | 61.48% | 0.34 | 1.01 | 0.07 | 60.72% | −0.31 | 89.51% | 7.23 | 11.77 | 2.17 | |||||
| Male Pre COVID - Follow-up 5 | −122.35 | 83.11% | −1.60 | 57.32% | 0.11 | 83.84% | 0.04 | 60.55% | 0.33 | 0.62 | 94.81% | 0.17 | 71.36% | 0.43 | 94.60% | 5.65 | 13.09 | 3.39 | ||||
| Female - Male: | −12.17 | 55.30% | 1.38 | 55.70% | 0.73 | 94.05% | 0.70 | 92.38% | −0.22 | 71.81% | 0.80 | 87.74% | −0.84 | 94.19% | −0.41 | 85.82% | 2.56 | −2.71 | 82.93% | −4.40 | ||
| Female - Male: | 79.53 | 62.44% | −0.19 | 50.67% | 0.82 | 0.75 | 93.51% | −0.23 | 75.11% | 0.41 | 72.06% | −0.74 | 91.71% | 0.32 | 79.81% | 1.00 | 84.05% | −1.40 | 79.79% | −3.16 | 90.68% | |
Note: values in bold exceed a 95% probability; IPAQ-E = International Physical Activity Questionnaire –Elderly; LLFDI = Late-Life Function and Disability Instrument; Dates = Follow-up 1 (13/6/2020), Follow-up 2 (5/9/2020) Follow-up 3 (12/12/2020), Follow-up 4 (6/3/2021), Follow-up 5 (5/6/2021).
Other question responses across all surveys.
Note: M = Male; F = Female; T = Total; All responses are Mean ± SD or n = number of participants.